ECVTEcovyst Inc.
$9.93+11% 1Y
$9.93
$7.8452 weeks$14.97
The financials
Ecovyst Inc. by the numbers
Ecovyst Inc. (ECVT) reported revenue of $250M in Q2 2026 (quarter ended Jun 30, 2026), up 42% from the same quarter a year earlier. That came with a gross margin of 20% and net income of $7.9M (3.1% of revenue). For the full year FY2025, revenue was $724M (+21% year on year) and net income −$71M. Its largest product in Q2 2026 was Virgin Sulfuric Acid at $138M, 55% of the disclosed total, ahead of Regenerated Sulfuric Acid And Treatment Services at 41%. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $250M | $176M | +42% |
| Gross profit | $50M | $40M | +24% |
| Operating income | $19M | $16M | +23% |
| Net income | $7.9M | $6.0M | +31% |
| Diluted EPS | $0.07 | $0.05 | +40% |
| Product | Revenue | Share |
|---|---|---|
| Virgin Sulfuric Acid | $138M | 55% |
| Regenerated Sulfuric Acid And Treatment Services | $103M | 41% |
| Catalyst Activation And Sulfur Dioxide Derivatives | $9.4M | 3.7% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $250.0M (+16%)
Virgin Sulfuric Acid grew +85% year on yearCatalyst Activation And Sulfur Dioxide Derivatives +4.6% year on year
Segment Latestyear on year
- Virgin Sulfuric Acid$137.5M$137.5Myear on year +85%+85%
- Regenerated Sulfuric Acid And Treatment Services$103.1M$103.1Myear on year +11%+11%
- Catalyst Activation And Sulfur Dioxide Derivatives$9.4M$9.4Myear on year +4.6%+4.6%
On our screens:Quality at a reasonable price